Good Manufacturing Practices (GMP) - Inspection Summary Reports

Drugs made in Canada or abroad must meet high safety and quality standards before they can be sold to Canadians. Health Canada licenses and regularly inspects companies that make, package, test, import, distribute and wholesale drugs.

Health Canada recently launched a new searchable database that includes detailed report cards of our inspections:

• The Drug and Health Product Inspections Database

To learn more about how we conduct drug inspections visit:

• About drug inspections

Inspection Summary Reports

Last year Health Canada published two summaries for inspections with a high level of public interest. These summary reports are in a different format than our inspection report cards and provide a chronological, step-by-step summary. In future, these summaries will also be available in the Drug and Health Product Inspections database.

• Summary Report - Apotex Pharmachem Inc.
• Summary Report - ID Biomedical Corporation of Quebec (GSK)
• Frequently Asked Questions - GlaxoSmithKline, ID Biomedical, Sainte-Foy Facility - Posting of Health Canada June 2014 Inspection Summary Report